 |
|
Researchers use chemical from medicinal plants to fight HIV
November 10, 2008TAT2, used in Chinese herbal therapy, prolongs killer T-cells' ability to divide
Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised.
But a new UCLA AIDS Institute study has found that a chemical from the Astragalus root, frequently used in Chinese herbal therapy, can prevent or slow this progressive telomere shortening, which could make it a key weapon in the fight against HIV.
"This has the potential to be either added to or possibly even replace the HAART (highly active antiretroviral therapy), which is not tolerated well by some patients and is also costly," said study co-author Rita Effros, a professor of pathology and laboratory medicine at the David Geffen School of Medicine at UCLA and member of the UCLA AIDS Institute.
The study, to be published in the Nov. 15 print edition of the Journal of Immunology, is available online at http://www.jimmunol.org/cgi/content/full/181/10/7400
A telomere is a region at the end of every cell chromosome that contains repeated DNA sequences but no genes; telomeres act to protect the ends of the chromosomes and prevent them from fusing together - rather like the plastic tips that keep shoelaces from unraveling. Each time a cell divides, the telomeres get shorter, eventually causing the cell to reach a stage called replicative senescence, when it can no longer divide. This seems to indicate that the cell has reached an end stage, but, in fact, the cell has changed into one with new genetic and functional characteristics.
A great deal of cell division must take place within the immune system for the system to function properly. For example, the so-called "killer" CD8 T-cells that help fight infection have unique receptors for particular antigens. When a virus enters the body, the killer T-cells whose receptors recognize that virus create, through division, versions of themselves that fight the invader.
Generally, the telomeres in cells are sufficiently long that they can divide many times without a problem. Moreover, when fighting infections, T-cells can turn on an enzyme called telomerase, which can prevent the telomeres from shortening.
"The problem is that when we're dealing with a virus that can't be totally eliminated from the body, such as HIV, the T-cells fighting that virus can't keep their telomerase turned on forever," Effros said. "They turn off, and telomeres get shorter and they enter this stage of replicative senescence."
Previous studies have shown that injecting the telomerase gene into T-cells can keep the telomeres from shortening, enabling them to maintain their HIV-fighting function for much longer. This gene-therapy approach, however, is not a practical way to treat the millions of people living with HIV.
For the present study, rather than utilizing gene therapy, the researchers used a chemical called TAT2, which was originally identified from plants used in traditional Chinese therapy and which enhances telomerase activity in other cell types.
They tested TAT2 in several ways. First, they exposed the CD8 T-cells from HIV-infected persons to TAT2 to see if the chemical not only slowed the shortening of the telomeres but improved the cells' production of soluble factors called chemokines and cytokines, which had been previously shown to inhibit HIV replication. It did.
They then took blood samples from HIV-infected individuals and separated out the CD8 T-cells and the CD4 T-cells - those infected with HIV. They treated the CD8 T-cells with TAT2 and combined them with the CD4 T-cells in the dish-and found that the treated CD8 cells inhibited production of HIV by the CD4 cells.
"The ability to enhance telomerase activity and antiviral functions of CD8 T-lymphocytes suggests that this strategy could be useful in treating HIV disease, as well as immunodeficiency and increased susceptibility to other viral infections associated with chronic diseases or aging," the researchers write.
University of California - Los Angeles
"This has the potential to be either added to or possibly even replace the HAART (highly active antiretroviral therapy), which is not tolerated well by some patients and is also costly," said study co-author Rita Effros, a professor of pathology and laboratory medicine at the David Geffen School of Medicine at UCLA and member of the UCLA AIDS Institute.
The study, to be published in the Nov. 15 print edition of the Journal of Immunology, is available online at http://www.jimmunol.org/cgi/content/full/181/10/7400
A telomere is a region at the end of every cell chromosome that contains repeated DNA sequences but no genes; telomeres act to protect the ends of the chromosomes and prevent them from fusing together - rather like the plastic tips that keep shoelaces from unraveling. Each time a cell divides, the telomeres get shorter, eventually causing the cell to reach a stage called replicative senescence, when it can no longer divide. This seems to indicate that the cell has reached an end stage, but, in fact, the cell has changed into one with new genetic and functional characteristics.
A great deal of cell division must take place within the immune system for the system to function properly. For example, the so-called "killer" CD8 T-cells that help fight infection have unique receptors for particular antigens. When a virus enters the body, the killer T-cells whose receptors recognize that virus create, through division, versions of themselves that fight the invader.
Generally, the telomeres in cells are sufficiently long that they can divide many times without a problem. Moreover, when fighting infections, T-cells can turn on an enzyme called telomerase, which can prevent the telomeres from shortening.
"The problem is that when we're dealing with a virus that can't be totally eliminated from the body, such as HIV, the T-cells fighting that virus can't keep their telomerase turned on forever," Effros said. "They turn off, and telomeres get shorter and they enter this stage of replicative senescence."
Previous studies have shown that injecting the telomerase gene into T-cells can keep the telomeres from shortening, enabling them to maintain their HIV-fighting function for much longer. This gene-therapy approach, however, is not a practical way to treat the millions of people living with HIV.
For the present study, rather than utilizing gene therapy, the researchers used a chemical called TAT2, which was originally identified from plants used in traditional Chinese therapy and which enhances telomerase activity in other cell types.
They tested TAT2 in several ways. First, they exposed the CD8 T-cells from HIV-infected persons to TAT2 to see if the chemical not only slowed the shortening of the telomeres but improved the cells' production of soluble factors called chemokines and cytokines, which had been previously shown to inhibit HIV replication. It did.
They then took blood samples from HIV-infected individuals and separated out the CD8 T-cells and the CD4 T-cells - those infected with HIV. They treated the CD8 T-cells with TAT2 and combined them with the CD4 T-cells in the dish-and found that the treated CD8 cells inhibited production of HIV by the CD4 cells.
"The ability to enhance telomerase activity and antiviral functions of CD8 T-lymphocytes suggests that this strategy could be useful in treating HIV disease, as well as immunodeficiency and increased susceptibility to other viral infections associated with chronic diseases or aging," the researchers write.
University of California - Los Angeles
Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Flavonoids Antarctic Gold Nanoparticles Triglycerides Racial discrimination Asteroids Allergic Reaction Esophageal Cancer Cell Division Amniotic Fluid Green Tea HIV Calorie restriction AIDS vaccine Allergies Breastfeeding Marriage Learning Health Care Radiation dose Wrinkles Huntingtons Disease Bipolar Spintronics Nuclear Medicine
See More: Science News Tags
HIV Current Events and HIV News RSSHarvard scientists solve mystery about why HIV patients are more susceptible to TB infection
A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection.
Teens who believe they'll die young are more likely to engage in risky behavior, University of Minnesota research finds
University of Minnesota Medical School researcher Iris Borowsky, M.D., Ph.D., and colleagues found that one in seven adolescents believe that it is highly likely that they will die before age 35, and this belief predicted that the adolescents' would engage in risky behaviors.
Gladstone scientists identify key factor that controls HIV latency
Scientists at the Gladstone Institutes of Virology and Immunology (GIVI) have found another clue that may lead to eradication of HIV from infected patients who have been on antiretroviral therapy.
MicroRNAs help control HIV life cycle
Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specific microRNAs (non-coding RNAs that interfere with gene expression) reduce HIV replication and infectivity in human T-cells.
UT School of Public Health researchers develop game for HIV+ youth
Researchers at The University of Texas School of Public Health have developed a game for HIV-positive youth, +CLICK, designed to reduce secondary transmission of the virus.
New electron microscopy images reveal the assembly of HIV
Scientists at the European Molecular Biology Laboratory (EMBL) and the University Clinic Heidelberg, Germany, have produced a three-dimensional reconstruction of HIV (Human Immunodeficiency Virus), which shows the structure of the immature form of the virus at unprecedented detail.
Transplant drug stimulates immune memory
Rapamycin, a drug given to transplant recipients to suppress their immune systems, has a paradoxical effect on cells responsible for immune memory, scientists at the Emory Vaccine Center have discovered.
A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy
A discovery by a team of Canadian and American researchers could provide new ways to fight HIV-AIDS. According to a new study published in Nature Medicine, HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments.
Researchers uncover approach for possibly eradicating HIV infection
Researchers from the newly-established VGTI Florida and the University of Montreal have uncovered a possible method for eradicating HIV infection in the human body.
Global health funding soars, boosted by unprecedented private giving
Well-heeled donors, private corporations and average citizens sending money to their favorite charities are changing the landscape of global health funding.
More HIV Current Events and HIV News Articles
 |
100 Questions and Answers About HIV and AIDS by Joel Gallant (Author) |
 |
Home Access HIV - 1 Express Test System - 1 ea by Home Access HIV-1 Test System is easy to use. Each test kit comes with a detailed instructions booklet with illustrations which will take you through pre-test registration and counseling; collecting a blood sample; shipping that sample to our accredited laboratory an |
 |
Absolutely Positive Directed By: Peter Adair Also With: Janet Cole (Cinematographer), Peter Adair (Cinematographer), Peter Adair (Writer) Ten years following its ground-breaking debut at Sundance, the landmark film that first humanized the face of AIDS is now available in this special 10th Anniversary Edition. Simultaneously heart-wrenching and life affirming, ABSOLUTELY POSITIVE is an hon |
 |
HIV and the Pathogenesis of AIDS, 3rd Edition by Jay A. Levy (Author) The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed. Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and... |
 |
Home Access HIV - 1 Test System - 1 ea by Home Access Home Access Hiv-1 Test System |
 |
The First Year: HIV: An Essential Guide for the Newly Diagnosed (First Year, The) by Brett Grodeck (Author), M.D. Daniel S. Berger (Foreword) This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans. |
 |
The First Year: HIV: An Essential Guide for the Newly Diagnosed by Da Capo Press Close to one million people are infected with HIV-the virus that causes AIDS-in the U.S., and though in the last ten years therapies have been developed to successfully fight both the HIV infection and its associated illnesses, the physical and emotional tolls are devastating. In the tradition of the other titles in the First Year(tm) series, The First Year(tm)-HIV uses a unique approach-guiding readers through their first seven days following diagnosis, then the next three weeks of their first month, and finally the next eleven months of their first year-to provide answers and advice that will help everyone newly diagnosed with HIV come to terms with their condition and the lifestyle changes that accompany it. Starting with the day of diagnosis, author Brett Grodeck provides vital... |
 |
HIV GIANT MICROBE by Giant Microbes H.I.V. kills CD4 cells, or T-helper cells ? Once the immune system is compromised, a person develops AIDS (acquired immuno-deficiency syndrome) ? H.I.V. is most commonly transmitted by sexual contact with an infected person ? Insect bites and sweat carry almost no risk of transmission ? Studies show that drying H.I.V. infected fluids can reduce viral presence by 90-99% ? There is no vaccine for H.I.V. and no cure for AIDS |
 |
Life Support Starring: Queen Latifah, Anna Deavere Smith, Wendell Pierce, Rachel Nicks, Evan Ross (III) Directed By: Nelson George HBO Films presents Academy Award® nominee Queen Latifah (Chicago) in a heartbreaking story of one woman's journey to the brink of self-destruction and despair, and her inspirational fight to gain back her dignity and her family. Ana is an HIV-positive former drug addict from Brooklyn, desperately struggling with her past and passionately trying to make things right with her involvement in an AIDS outreach group, Life Support. Inspired by a true story, Life Support is a touching, poignant tale of loving, losing and letting go. DVD Features: |
 |
AIDS and HIV Answers Starring: Artist Not Provided Studio: Victor Multimedia-05 Release Date: 09/18/2007 Run time: 22 minutes |
| © 2009 BrightSurf.com |